70 related articles for article (PubMed ID: 1803324)
1. Lack of mutations in the TP53 tumor suppressor gene exons 5 to 8 in Fanconi's anemia.
Jonveaux P; Le Coniat M; Grausz D; Berger R
Nouv Rev Fr Hematol (1978); 1991; 33(5):343-5. PubMed ID: 1803324
[TBL] [Abstract][Full Text] [Related]
2. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H
J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620
[TBL] [Abstract][Full Text] [Related]
3. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
Law JC; Strong LC; Chidambaram A; Ferrell RE
Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
[TBL] [Abstract][Full Text] [Related]
4. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
5. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy.
Rischewski JR; Clausen H; Leber V; Niemeyer C; Ritter J; Schindler D; Schneppenheim R
Klin Padiatr; 2000; 212(4):174-6. PubMed ID: 10994546
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.
Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M
Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849
[TBL] [Abstract][Full Text] [Related]
7. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
9. Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma.
van Meyel DJ; Ramsay DA; Chambers AF; Macdonald DR; Cairncross JG
Ann Neurol; 1994 Jan; 35(1):120-2. PubMed ID: 8285583
[TBL] [Abstract][Full Text] [Related]
10. Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel.
Peleg L; Pesso R; Goldman B; Dotan K; Omer M; Friedman E; Berkenstadt M; Reznik-Wolf H; Barkai G
Isr Med Assoc J; 2002 Feb; 4(2):95-7. PubMed ID: 11876000
[TBL] [Abstract][Full Text] [Related]
11. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
12. The FANCA gene in Japanese Fanconi anemia: reports of eight novel mutations and analysis of sequence variability.
Tachibana A; Kato T; Ejima Y; Yamada T; Shimizu T; Yang L; Tsunematsu Y; Sasaki MS
Hum Mutat; 1999; 13(3):237-44. PubMed ID: 10090479
[TBL] [Abstract][Full Text] [Related]
13. Aberrations of the CHK2 gene are rare in pediatric solid tumors.
Chen YY; Takita J; Tanaka K; Ida K; Koh K; Igarashi T; Hanada R; Kikuchi A; Tanaka Y; Toyoda Y; Hayashi Y
Int J Mol Med; 2005 Jul; 16(1):85-91. PubMed ID: 15942682
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
15. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
[TBL] [Abstract][Full Text] [Related]
16. Identification of Alu-mediated deletions in the Fanconi anemia gene FAA.
Levran O; Doggett NA; Auerbach AD
Hum Mutat; 1998; 12(3):145-52. PubMed ID: 9711872
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
18. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews.
Whitney MA; Saito H; Jakobs PM; Gibson RA; Moses RE; Grompe M
Nat Genet; 1993 Jun; 4(2):202-5. PubMed ID: 8348157
[TBL] [Abstract][Full Text] [Related]
19. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
[TBL] [Abstract][Full Text] [Related]
20. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
Shuin T; Kondo K; Torigoe S; Kishida T; Kubota Y; Hosaka M; Nagashima Y; Kitamura H; Latif F; Zbar B
Cancer Res; 1994 Jun; 54(11):2852-5. PubMed ID: 8187067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]